OSLI Retina

December 2019

Issue link: http://osliretina.healio.com/i/1191488

Contents of this Issue

Navigation

Page 65 of 67

808 Ophthalmic Surgery, Lasers & Imaging Retina | Healio.com/OSLIRetina News and Notes News and Notes Cedars-Sinai Receives $10.5 Million to Study RP Stem Cell Treatment Cedars-Sinai researchers have received a $10.5 million grant from the California Institute for Regenerative Medicine (CIRM) to launch a clinical trial evaluating stem cell technology for the treatment of retinitis pigmentosa (RP), according to a press release. The trial includes injecting CNS10-NPC, a cortical progenitor cell product, into one eye of up to 16 patients with RP. Vision in both eyes of each patient will be compared and overall safety evaluated. "We want to make sure the injections do not have unwanted side effects, such as surgical complications or an immune reaction," Clive Svendsen, PhD, the tri- al's principal investigator, said. Preclinical research of the treatment, which led to the U.S. Food and Drug Administration's trial approval, was also funded by a CIRM grant. "Throughout our years of painstaking research on RP, CIRM has been a steady partner and supporter of our work," Svendsen said. "This $10.5 million award will propel us into the next phase of our effort by allowing us to move forward with a clinical trial." Originally posted on www.Healio.com on November 8, 2019. Ophthalmic Surgery, Lasers & Imaging Retina® (ISSN-2325-8160, Canadian BN-12978 0466 RT ) is published 12 times per year by SLACK Incorporated®, and is an official publication of ARVO/ISIE. Publication Office: SLACK Incorporated®, 6900 Grove Road, Thorofare, NJ 08086-9447. Telephone (856) 848-1000. Printed in the USA. Periodicals Class Postage Paid at Deptford, NJ 08096 and at additional mailing offices. Contents copyrighted by SLACK Incorporated®, 2019. All rights reserved. No part of this publication may be reproduced with- out prior written consent of the publisher. All requests to reprint or use material published herein should be directed to the Request Permissions link on every article page at Healio.com/ophthalmology/journals/osli. Subscription rates in the U.S. and possessions: Individuals: One year—print $228, electronic only: $203. Institutional: One year—$719. Residents and fellows: $114 for one year (a letter of certification indicating residency of the subscriber is required). Canada add 5% GST, all other countries add $64 per year. All subscriptions, without exception, will start with the first issue pub- lished after the order is received. Single copies and back issues, when available, are $103. Payment must accompany order. Sub- scription requests should be addressed to the publisher. Change of Address: Notice should be sent to the publisher six weeks in advance of effective date. Include old and new ad- dresses with zip codes. The publisher cannot accept responsibility for undelivered copies. Duplicate copies will not be sent to re- place ones undelivered through failure to notify the publisher of change of address. POSTMASTER: Send Form 3547 to Ophthalmic Surgery, Lasers & Imaging Retina®, SLACK Incorporated®, 6900 Grove Road, Thorofare, NJ 08086-9447. Articles are intended for informational purposes only and should not be used as the basis of patient treatment. All opinions expressed by authors and quoted sources are their own and do not necessarily reflect the opinions of the editors, publisher, or editorial boards of SLACK Incorporated®. The acceptance of advertising in no way implies endorsement by the editors, publisher, or editorial boards of SLACK Incorporated®. See website for print and web advertising policy. Readers with queries about the Journal's policies on error correction, version control, journal of record, ancillary material, or archiving should contact osli@healio.com. The Journal staff have no financial relationships to disclose. Financial disclosures for the Editor and members of the Editorial Board are on file with the editorial office. Indexed in: Medline/PubMed, ProQuest, EMCare, EMBASE, Science Citation Index, Current Contents/Clinical Medicine, BioEn- gineering Abstracts, CAB Abstracts, and SCOPUS. Follow OSLIJournal OSLI Retina SLACK Incorporated 6900 Grove Road Thorofare, NJ 08086-9447 Phone: 856-994-9900 Email: osli@healio.com Healio.com/OSLIRetina Chief Content Officer Joan-Marie Stiglich, ELS EDITORIAL Senior Editorial Director David W. Mullin Executive Editor Cara Dickinson SALES Chief Commercial Officer Matthew J. Holland Group Sales Director, Eye Care Scott Wright Senior Account Manager Kathy Huntley National Account Manager Laura Renna Director, Sales Administration and Support Carolyn Boerner Sales Coordinator, Recruitment Jennifer Carroll Classified/Recruitment Sales KERH Group LLC 855-233-8100 slack@kerhgroup.com Reprints/Eprints Licensing Opportunities: Sheridan Content Solutions scsreprints@sheridan.com DESIGN Creative Director Thomas Cavallaro Production and Circulation Director Cheryl McKeown Production Associate Ryan Davis The Wyanoke Group President Peter N. Slack Chief Operating Officer John C. Carter Chief Financial Officer Darrell Blood Senior Vice President Denise Mealey Chief Technology Officer Linda Baker

Articles in this issue

Links on this page

Archives of this issue

view archives of OSLI Retina - December 2019